66. IgA腎症 ［臨床試験数：199，薬物数：214（DrugBank：57），標的遺伝子数：32，標的パスウェイ数：128］
Searched query = "IgA nephropathy", "IgA nephritis", "Berger disease", "IgA-IgG nephropathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||NCT03015974||January 2016||3/1/2017||Registry of IgA Nephropathy in Chinese Children||Registry of IgA Nephropathy in Chinese Children||IgA Nephropathy;Proteinuria in Nephrotic Range;Immunosuppressive Treatment||Drug: Corticosteroid;Drug: Cyclophosphamide;Drug: Mycophenolate mofetil;Drug: Dipyridamole;Drug: ACE Inhibitor or Angiotensin receptor antagonist||Peking University First Hospital||Nanjing PLA General Hospital;Beijing Children's Hospital;Central South University;The Children's Hospital of Zhejiang University School of Medicine;First Affiliated Hospital, Sun Yat-Sen University;Tongji Hospital;Hunan Children's Hospital;Shanghai Children's Hospital;Nanjing Children's Hospital;Children's Hospital of Chongqing Medical University;Shandong Provincial Hospital;Fuzhou General Hospital;Second Affiliated Hospital of Wenzhou Medical University;Children's Hospital of Hebei Province;Guangzhou Women and Children's Medical Center;Jiangxi Province Children's Hospital;Guangzhou First People's Hospital;Xian Children's Hospital;Capital Institute of Pediatrics, China;First Hospital of Jilin University;Wuhan Women and Children's Medical Center;Tianjin Children's Hospital;Chengdu Women's and Children's Central Hospital;The First People's Hospital of Yunnan||Recruiting||1 Month||18 Years||All||1200||China|
|2||ChiCTR-TRC-13003038||2013-01-01||2013-01-11||Mizoribine for the Treatment of Pediatric IgA Nephropathy||Mizoribine for the Treatment of Pediatric IgA Nephropathy with Moderate Proteinuria--An open, prospective, random, multicenter study||IgA nephropathy||MZR:mizoribine tablet 4 mg/kg a day (not more than 150 mg/d), qd, po + Dipyridamole, 3 mg/kg a day (not more than 25 mg at a time), tid, po;CVT:Lotensin, 0.2 mg/kg a day (not more than 10 mg/d), qd, po + + Dipyridamole, 3 mg/kg a day (not more than 25 mg at a time), tid, po;||Peking University First Hospital||NULL||Completed||6||18||Both||MZR:60;CVT:60;||China|
|3||JPRN-C000000363||2001/08/01||14/05/2007||A combination of prednisolone and mizoribine and a combination of prednisolone, mizoribine, warfarin and dipyridamole for IgA nephropathy with diffuse mesangial prolideration in children:A randomized controlled trial of efficacy and safety||IgA nephropathy in children||prednisolone+mizoribine for 2 years |
prednisolone+mizoribine+warfarin+dipyridamole for 2 years
|The Japanese Pediatric IgA Nephropathy ofTreatment Study Group||NULL||Complete: follow-up complete||2years-old||18years-old||Male and Female||80||Not selected||Japan|
|4||JPRN-C000000375||1998/08/01||01/04/2006||A combination of prednisolone, mizoribine, warfarin and dipyridamole for IgA nephropathy with nephrotic syndrome and diffuse mesangial proliferation in children.||IgA nephropathy in children||prednisolone+mizoribine+warfarin+dipyridamole for 2 years||The Japanese Pediatric IgA Nephropathy of Treatment Study Group||NULL||Complete: follow-up complete||2years-old||18years-old||Male and Female||20||Not selected||Japan|
|5||JPRN-C000000374||1998/08/01||01/04/2006||A combination of prednisolone, warfarin and dipyridamole for IgA nephropathy with diffuse mesangial proliferation in children.||IgA nephropathy in children||prednisolone+warfarin+dipyridamole for 2 years||The Japanese Pediatric IgA Nephropathy ofTreatment Study Group||NULL||Complete: follow-up complete||2years-old||18years-old||Male and Female||20||Not selected||Japan|